VANDA PHARMA (VM4.SG)
VANDA PHARMA (VM4.SG) operates in Diversified Metals & Mining.
VANDA PHARMA (VM4.SG) (VM4) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: -0.027x
Based on the latest financial reports, VANDA PHARMA (VM4.SG) (VM4) has a cash flow conversion efficiency ratio of -0.027x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-14.58 Million) by net assets (€541.22 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
VANDA PHARMA (VM4.SG) - Cash Flow Conversion Efficiency Trend (2016–2023)
This chart illustrates how VANDA PHARMA (VM4.SG)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
VANDA PHARMA (VM4.SG) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of VANDA PHARMA (VM4.SG) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
EKTR3F
SA:EKTR3F
|
N/A |
|
NORSK HYDRO - Dusseldorf Stock Exchang
DU:NOH1
|
0.044x |
|
Trustpilot Group PLC
LSE:TRST
|
0.675x |
|
TAKIX
NMFQS:TAKIX
|
N/A |
|
HZOZD
PINK:HZOZD
|
N/A |
|
AMBAC FINL GRP (FGPN.SG)
STU:FGPN
|
0.010x |
|
FULLER SMITH+TURN.A LS-40
F:1ZJ
|
N/A |
|
Emperador Properties SOCIMI S.A.
MC:YEPSA
|
N/A |
Annual Cash Flow Conversion Efficiency for VANDA PHARMA (VM4.SG) (2016–2023)
The table below shows the annual cash flow conversion efficiency of VANDA PHARMA (VM4.SG) from 2016 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | €544.91 Million | €12.80 Million | 0.023x | -61.28% |
| 2022-12-31 | €527.20 Million | €31.98 Million | 0.061x | -52.30% |
| 2021-12-31 | €504.93 Million | €64.21 Million | 0.127x | +11.34% |
| 2020-12-31 | €453.27 Million | €51.77 Million | 0.114x | +2.16% |
| 2019-12-31 | €410.94 Million | €45.95 Million | 0.112x | +2.70% |
| 2018-12-31 | €275.42 Million | €29.99 Million | 0.109x | +821.36% |
| 2017-12-31 | €131.39 Million | €-1.98 Million | -0.015x | +75.54% |
| 2016-12-31 | €131.33 Million | €-8.10 Million | -0.062x | -- |